PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Academic Keys
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- Geneva Foundation for Medical Education and Research
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Maya Krishnamurthy
Department of Pharmacology, Mallige College of Pharmacy, Karnataka, India
Publications
-
Research Article
Depression and Anxious during COVID-19
Author(s): Maya Krishnamurthy*, NC Nagalakshmi, Chaurasiya Raunakkumar and Yeshwant Kumar
According to the COVID-19 mental disorders collaborators, major depressive disorder cases worldwide increased by 276 percent and anxiety disorder cases increased by 256 percent in 2020 as a result of the pandemic. But we argue that these prevalence estimates are probably much exaggerated. Years of trauma study have demonstrated that most people have resilience (little impact on symptoms of anxiety, depression, or both) or recovery in the wake of traumatic life experiences like bereavement or catastrophe exposure (initial short-term increase in symptoms of anxiety, or depression, or both, followed by recovery). This trend is consistent with what in-depth analyses and investigations have shown about COVID-19. Because the authors' estimations of COVID-19's impact are based solely on studies conducted predominantly during the very early phase of the pandemic, psychologic.. View more»